A Comprehensive View of IHC Biomarkers
Explore our immunohistochemistry biomarkers supporting tissue analysis, biomarker discovery, and clinical research applications.
Answer Critical Clinical Questions with Strategic Biomarker Solutions
Develop biomarker strategies tailored to your program, combining scientific expertise and integrated technologies to deliver meaningful evidence throughout development.
Turn biomarker insights into confident clinical decisions
Every biomarker decision influences the clinical questions your data can answer. The choices you make around biomarker strategy, technology selection, and analytical approach determine the relevance of the evidence generated throughout your development program.
From exploratory research through clinical trials and commercialization, we partner with you to design and implement biomarker strategies tailored to your objectives. By integrating complementary technologies and scientific expertise, we help you translate complex biological signals into meaningful evidence that supports critical development decisions.
With expertise across diverse therapeutic areas and biomarker modalities, our teams help you connect disease biology, patient response, and biomarker data to the questions that matter most to your program.
Why choose Cerba Research?
Supporting your biomarker strategy across clinical development
We support your biomarker programs with integrated capabilities spanning assay development, analytical technologies, and data generation, helping you move from discovery to clinically meaningful insights.
Biomarker strategy and study design
Defining the right biomarker strategy early helps ensure your study generates meaningful, actionable data.
We work with you to design biomarker approaches aligned to your clinical objectives, supporting endpoint selection, patient stratification, and data generation from the outset.
Capabilities include:
- Biomarker strategy design
- Endpoint and assay selection support
- Feasibility assessment and scientific consultation
- Integration with protocol development
Biomarker assay development and validation
Once your biomarker strategy is defined, assays must be optimized and validated to deliver reliable, reproducible results.
We develop, optimize, and validate assays aligned to their intended use, supporting both exploratory and clinical applications.
Capabilities include:
- Custom assay development
- Fit-for-purpose validation
- Performance and sensitivity characterization
- Validation documentation and reporting
Multi-modal biomarker testing
Understanding disease biology often requires combining multiple biomarker approaches rather than relying on a single test.
We generate complementary data across biomarker types using a broad range of analytical technologies, supporting a more complete view of treatment response.
Capabilities include:
- Genomic and molecular testing
- Immunological and cell-based assays
- Protein and ligand-binding assays
- Tissue biomarker analysis
Data integration and interpretation
As biomarker data becomes more complex, integrating and interpreting results is critical to extracting meaningful clinical insight.
We bring together data across platforms and studies to connect biomarker findings with clinical outcomes and decision-making.
Capabilities include:
- Cross-modality data integration
- Interpretation aligned to study endpoints
- Reporting and analytical outputs
- Support for decision-making
Supporting services for your biomarker strategy
Genomics
Generate molecular insights through advanced sequencing and genomic testing solutions.
Flow cytometry
Develop and validate customized panels for immune monitoring and biomarker-driven research.
Histopathology
Support tissue biomarker strategies with assay development, validation, and pathology expertise
Assay development and technology transfer
Develop and deploy robust assays aligned to your biomarker strategy and study objectives.
Bioanalytical solutions
Support pharmacokinetic, pharmacodynamic, and immunogenicity biomarker assessments.
Protocol development
Align laboratory and biomarker strategies with study design and clinical endpoints.
Biomarker insights and resources
The Value of Biomarkers from Discovery Through Commercialization
Understand how integrated biomarker strategies drive smarter clinical decisions, support precision medicine, and enhance outcomes across the drug development lifecycle.
Analyzing Multiple Biomarkers with IHC: Putting a 6-Plex Kit to the Challenge
See how multiplex immunohistochemistry enables simultaneous analysis of multiple biomarkers, supporting deeper insights into tissue biology and more efficient biomarker evaluation.
Biomarkers in Immuno-Oncology: From Exploratory Research to Clinical
Learn how biomarker strategies evolve from early research through to clinical implementation, supporting patient selection, treatment response assessment, and clinical decision-making in immuno-oncology.
Biomarkers in Colorectal Cancer
Understand the complex biomarker landscape in colorectal cancer, including key genomic and molecular markers such as KRAS, NRAS, BRAF, and MSI, and how integrated testing approaches support precision treatment strategies
Biomarkers in Breast Cancer
Explore critical biomarkers such as HER2, ER, PR, and emerging targets that support patient stratification and targeted therapy development across diverse breast cancer subtypes.
Biomarkers in Lung Cancer
Discover key biomarkers driving precision medicine in lung cancer, including EGFR, ALK, KRAS, and PD-L1, and how comprehensive molecular profiling supports effective therapeutic development.
